cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ventyx Biosciences Inc
4 own
2 watching
Current Price
$2.96
$0.06
(1.9%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
137.26M
52-Week High
52-Week High
38.20000
52-Week Low
52-Week Low
1.86500
Average Volume
Average Volume
0.61M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization137.26M
icon52-Week High38.20000
icon52-Week Low1.86500
iconAverage Volume0.61M
iconDividend Yield--
iconP/E Ratio--
What does the Ventyx Biosciences Inc do?
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company s lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases which is in phase I clinical trials. In addition, the company develops CNS-penetrant NLRP3 inhibitors for the treatment of Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and multiple sclerosis. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.
Read More
How much money does Ventyx Biosciences Inc make?
News & Events about Ventyx Biosciences Inc.
Fool.com Headlines
1 year ago
The company has several promising autoimmune therapies.On Monday, shares of Ventyx Biosciences (NASDAQ: VTYX) closed 22.87% higher than they did last week. The clinical-stage biotech hit more than $40 a share for the first time since March 10.Ventyx focuses on therapies to treat inflammatory ...
Zolmax
1 year ago
Ventyx Biosciences, Inc. (NASDAQ:VTYX Get Rating) insider William J. Sandborn sold 3,487 shares of the firms stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $34.15, for a total value of $119,081.05. Following the transaction, the ...
Ticker Report
1 year ago
Ventyx Biosciences (NASDAQ:VTYX Get Rating) had its price target trimmed by Oppenheimer from $65.00 to $62.00 in a research report report published on Friday, Benzinga reports. The brokerage currently has an outperform rating on the stock. Oppenheimer also issued estimates for Ventyx ...
Ticker Report
1 year ago
Ventyx Biosciences, Inc. (NASDAQ:VTYX Get Rating) Stock analysts at Oppenheimer issued their FY2026 EPS estimates for shares of Ventyx Biosciences in a report issued on Sunday, March 19th. Oppenheimer analyst J. Jones forecasts that the company will post earnings per share of ($2.75...
Globe Newswire
1 year ago
ENCINITAS, Calif., March 24, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (Ventyx), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that ...
Frequently Asked Questions
Frequently Asked Questions
What is Ventyx Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Ventyx Biosciences Inc shares?
plus_minus_icon
How can I buy Ventyx Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Ventyx Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ventyx Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Ventyx Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Ventyx Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ventyx Biosciences Inc?
plus_minus_icon
What percentage is Ventyx Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ventyx Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.96
$0.06
(1.9%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00